Literature DB >> 33790412

Glucocorticoid treatment for non-cerebral diseases in children and adolescents is associated with differences in uncinate fasciculus microstructure.

Martin Vestergaard1,2, William F C Baaré1, Sara K Holm1,3, Camilla G Madsen1, Olaf B Paulson1,4,5,6, Alfred P Born3, Peter Uldall3, Hartwig R Siebner1,6,7, Kathrine Skak Madsen8,9,10.   

Abstract

BACKGROUND: Evidence suggests that fronto-limbic brain regions and connecting white matter fibre tracts in the left hemisphere are more sensitive to glucocorticoids than in the right hemisphere. It is unknown whether treatment with glucocorticoids in childhood is associated with microstructural differences of the uncinate fasciculus and cingulum bundle, which connect fronto-limbic brain regions. Here, we tested the hypothesis that prior glucocorticoid treatment would be associated with differences in fractional anisotropy (FA) of the left relative to right uncinate fasciculus and cingulum bundle.
METHODS: We performed diffusion-weighted imaging in 28 children and adolescents aged 7-16 years previously treated with glucocorticoids for nephrotic syndrome or rheumatic disease and 28 healthy controls.
RESULTS: Patients displayed significantly different asymmetry in the microstructure of uncinate fasciculus with higher left but similar right uncinate fasciculus FA and axial diffusivity compared to controls. No apparent differences were observed for the cingulum. Notably, higher cumulative glucocorticoid doses were significantly associated with higher uncinate fasciculus FA and axial diffusivity bilaterally.
CONCLUSIONS: Our findings indicate that previous glucocorticoid treatment for non-cerebral diseases in children and adolescents is associated with long-term changes in the microstructure of the uncinate fasciculi, and that higher cumulative glucocorticoid doses have a proportional impact on the microstructure. IMPACT: It is unknown if treatment with glucocorticoids in childhood have long-term effects on fronto-limbic white matter microstructure. The study examined if children and adolescents previously treated with glucocorticoids for nephrotic syndrome or rheumatic disorder differed in fronto-limbic white matter microstructure compared to healthy controls. The nephrotic and rheumatic patients had higher left but similar right uncinate fasciculus FA and axial diffusivity. Higher bilateral uncinate fasciculus FA and axial diffusivity was associated with higher cumulative glucocorticoid doses. We revealed new evidence suggesting that previous glucocorticoid treatment for non-cerebral diseases in children and adolescents is associated with long-term changes in uncinate fasciculi microstructure.
© 2021. The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33790412     DOI: 10.1038/s41390-021-01394-w

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.953


  42 in total

Review 1.  Brain mineralocorticoid receptors and centrally regulated functions.

Authors:  E R de Kloet; S A Van Acker; R M Sibug; M S Oitzl; O C Meijer; K Rahmouni; W de Jong
Journal:  Kidney Int       Date:  2000-04       Impact factor: 10.612

Review 2.  Stress and the brain: from adaptation to disease.

Authors:  E Ron de Kloet; Marian Joëls; Florian Holsboer
Journal:  Nat Rev Neurosci       Date:  2005-06       Impact factor: 34.870

Review 3.  Exogenous glucocorticoids and adverse cerebral effects in children.

Authors:  Sara K Damsted; A P Born; Olaf B Paulson; Peter Uldall
Journal:  Eur J Paediatr Neurol       Date:  2011-05-31       Impact factor: 3.140

4.  Early developmental emergence of human amygdala-prefrontal connectivity after maternal deprivation.

Authors:  Dylan G Gee; Laurel J Gabard-Durnam; Jessica Flannery; Bonnie Goff; Kathryn L Humphreys; Eva H Telzer; Todd A Hare; Susan Y Bookheimer; Nim Tottenham
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-09       Impact factor: 11.205

Review 5.  Postnatal brain development: structural imaging of dynamic neurodevelopmental processes.

Authors:  Terry L Jernigan; William F C Baaré; Joan Stiles; Kathrine Skak Madsen
Journal:  Prog Brain Res       Date:  2011       Impact factor: 2.453

6.  Maternal Cortisol Concentrations During Pregnancy and Sex-Specific Associations With Neonatal Amygdala Connectivity and Emerging Internalizing Behaviors.

Authors:  Alice M Graham; Jerod M Rasmussen; Sonja Entringer; Elizabeth Ben Ward; Marc D Rudolph; John H Gilmore; Martin Styner; Pathik D Wadhwa; Damien A Fair; Claudia Buss
Journal:  Biol Psychiatry       Date:  2018-07-07       Impact factor: 13.382

Review 7.  Genomic and epigenomic mechanisms of glucocorticoids in the brain.

Authors:  Jason D Gray; Joshua F Kogan; Jordan Marrocco; Bruce S McEwen
Journal:  Nat Rev Endocrinol       Date:  2017-09-01       Impact factor: 43.330

8.  Developmental pathways to amygdala-prefrontal function and internalizing symptoms in adolescence.

Authors:  Cory A Burghy; Diane E Stodola; Paula L Ruttle; Erin K Molloy; Jeffrey M Armstrong; Jonathan A Oler; Michelle E Fox; Andrea S Hayes; Ned H Kalin; Marilyn J Essex; Richard J Davidson; Rasmus M Birn
Journal:  Nat Neurosci       Date:  2012-11-11       Impact factor: 24.884

Review 9.  The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights.

Authors:  Agnes E Coutinho; Karen E Chapman
Journal:  Mol Cell Endocrinol       Date:  2010-04-14       Impact factor: 4.102

10.  Associations between different dimensions of prenatal distress, neonatal hippocampal connectivity, and infant memory.

Authors:  Dustin Scheinost; Marisa N Spann; Laraine McDonough; Bradley S Peterson; Catherine Monk
Journal:  Neuropsychopharmacology       Date:  2020-04-18       Impact factor: 7.853

View more
  1 in total

Review 1.  Long-term effects of glucocorticoid excess on the brain.

Authors:  Alies J Dekkers; Jorge Miguel Amaya; Merel van der Meulen; Nienke R Biermasz; Onno C Meijer; Alberto M Pereira
Journal:  J Neuroendocrinol       Date:  2022-08-18       Impact factor: 3.870

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.